New York S 5352: Relates to requiring cable companies to charge the same rate for the same service

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S05352 Summary:

BILL NOS05352 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORCOMRIE

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §6810, Ed L

&nbsp

Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.

Go to top S05352 Actions:

BILL NOS05352 

&nbsp

02/20/2025REFERRED TO HIGHER EDUCATION

01/07/2026REFERRED TO HIGHER EDUCATION

Go to topS05352 Committee&nbspVotes:

Go to topS05352 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS05352 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 5352

 2025-2026 Regular Sessions

 IN SENATE

 February 20, 2025
 ___________

 Introduced by Sen. COMRIE -- read twice and ordered printed, and when
 printed to be committed to the Committee on Higher Education

 AN ACT to amend the education law, in relation to notification of the
 substitution of one generic drug product for another generic drug

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Subdivision 6 of section 6810 of the education law is
 2 amended by adding a new paragraph (b-1) to read as follows:
 3 (b-1) The prescriber or pharmacist shall inform the patient whether
 4 they have prescribed or substituted a different generic drug product
 5 from the generic drug product the patient has previously received.
 6 Notification required pursuant to this paragraph shall be provided both
 7 written and orally.
 8 § 2. This act shall take effect on the ninetieth day after it shall
 9 have become a law.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD09499-01-5

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps